Iranian researchers from Tabriz University of Medical Sciences studied the effect of a type of herbal compound on the treatment of breast cancer.
This material was produced in form of a nanocapsule by using biodegradable polymers. Laboratory results proved the appropriate performance of the nanodrug in the treatment of cancer cells.
Chrysin is extracted from honey and other plants. It has anti-inflammation, antioxidant and anti-allergic properties. Studied done in recent years show that chrysin is an appropriate option for cancer treatment because it prevents the proliferation of cancer cells.
Chrysin plays an important role in the prevention of the growth of cancer cells, and it reduces the cyclin D1 gene. Therefore, the researchers studied the effects of chrysin with pure and nano-encapsulated poly(lactic-co-glycolic acid) and polyethylene glycol (PLGA-PEG) forms on T-47D breast cancer and the cyclin D1 gene.
Based on the results, the use of nano-encapsulated chyrsin improved in effectiveness of the drug at low concentrations, and improved the delivery of low bioavailability anticancer drugs.
The results of the research have been published here.
